AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $249,000 | -5.0% | 5,750 | -23.3% | 0.10% | -21.0% |
| Q3 2020 | $262,000 | -34.7% | 7,500 | 0.0% | 0.12% | -37.4% |
| Q2 2020 | $401,000 | +24.1% | 7,500 | -17.6% | 0.20% | -3.9% |
| Q1 2020 | $323,000 | -25.7% | 9,100 | 0.0% | 0.21% | -1.0% |
| Q4 2019 | $435,000 | -6.9% | 9,100 | -36.8% | 0.21% | -10.0% |
| Q3 2019 | $467,000 | -33.1% | 14,400 | +2.9% | 0.23% | -39.5% |
| Q2 2019 | $698,000 | -33.2% | 14,000 | -9.7% | 0.38% | -31.5% |
| Q1 2019 | $1,045,000 | +40.8% | 15,500 | -3.7% | 0.56% | +16.7% |
| Q4 2018 | $742,000 | -61.8% | 16,100 | -36.0% | 0.48% | -53.4% |
| Q3 2018 | $1,940,000 | -8.4% | 25,150 | 0.0% | 1.02% | -10.3% |
| Q2 2018 | $2,118,000 | +3.0% | 25,150 | 0.0% | 1.14% | -0.4% |
| Q1 2018 | $2,057,000 | +30.6% | 25,150 | -8.7% | 1.15% | +36.3% |
| Q4 2017 | $1,575,000 | -15.3% | 27,550 | -1.1% | 0.84% | -27.7% |
| Q3 2017 | $1,859,000 | – | 27,850 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |